Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of the Lymphatic System01:15

Development of the Lymphatic System

2.7K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.7K
Lymphatic Vessels and Lymph Transport01:16

Lymphatic Vessels and Lymph Transport

24.8K
Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
24.8K
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

1.6K
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
1.6K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

906
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
906
Detailed Structure and Function of Lymph Nodes01:23

Detailed Structure and Function of Lymph Nodes

6.5K
Lymph nodes are bean-shaped structures that cluster along the lymphatic vessels in the inguinal, axillary, and cervical regions. Each node is divided into compartments by a capsule that extends trabeculae inward.
From a histological perspective, lymph nodes can be split into two main areas: the superficial cortex and the deep medulla. The outer cortex is populated by dendritic cells, macrophages, and B lymphocytes, which are densely packed into follicles. When these B-lymphocytes are presented...
6.5K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

4.2K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early and late-onset colorectal cancers: a case-case comparison of risk factors.

Cancer causes & control : CCC·2026
Same author

Availability and Use of Social Determinants of Health Data in Alliance Gastrointestinal Cancer Clinical Trials.

JCO oncology practice·2026
Same author

Moving Mountains: Improving Access to Autologous Stem Cell Transplant for Vulnerable Patient Populations.

Cancers·2026
Same author

Nonlinear Association Between Metabolic Syndrome Severity and Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Gastro hep advances·2026
Same author

Temporal trends in cancer-specific and other-cause mortality disparities in uterine cancer.

Cancer epidemiology·2026
Same author

Clinician Perspectives on Implementing Breast Cancer-Related Lymphedema Prospective Screening.

JAMA network open·2026

Related Experiment Video

Updated: Apr 11, 2026

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
09:50

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

Published on: November 2, 2019

8.8K

Symptoms: Lymphedema.

Electra D Paskett1

  • 1Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, USA, electra.paskett@osumc.edu.

Advances in Experimental Medicine and Biology
|June 11, 2015
PubMed
Summary

Breast cancer survivors often experience lymphedema, a condition causing swelling and pain. Further research is crucial for effective prevention, diagnosis, and treatment strategies to improve survivors' quality of life.

Area of Science:

  • Oncology
  • Medical Complications
  • Rehabilitation

Background:

  • Lymphedema is a significant late effect of breast cancer treatment, impacting 3-60% of survivors.
  • Symptoms include swelling, pain, and restricted movement, negatively affecting physical function and quality of life.
  • Lack of standardized prevention, diagnosis, and treatment methods highlights a critical gap in care.

Purpose of the Study:

  • To review the current landscape of breast cancer-related lymphedema.
  • To investigate existing prevention, risk reduction, diagnosis, and treatment strategies.
  • To identify future research opportunities and challenges, particularly for underserved populations.

Main Methods:

  • Literature review and synthesis of current knowledge on breast cancer-related lymphedema.

More Related Videos

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
05:44

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

Published on: January 12, 2017

10.7K
A Murine Tail Lymphedema Model
04:38

A Murine Tail Lymphedema Model

Published on: February 10, 2021

6.9K

Related Experiment Videos

Last Updated: Apr 11, 2026

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
09:50

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

Published on: November 2, 2019

8.8K
Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
05:44

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

Published on: January 12, 2017

10.7K
A Murine Tail Lymphedema Model
04:38

A Murine Tail Lymphedema Model

Published on: February 10, 2021

6.9K
  • Analysis of existing research on prevention, diagnosis, and treatment.
  • Identification of research gaps and future directions.
  • Main Results:

    • Breast cancer-related lymphedema is prevalent but poorly understood and under-researched.
    • Current management lacks standardized protocols.
    • Significant opportunities exist for research in prevention, quality of life, surveillance, and treatment.

    Conclusions:

    • Breast cancer-related lymphedema poses a substantial challenge to survivor well-being.
    • There is an urgent need for standardized approaches and increased research focus.
    • Future research should prioritize underserved populations and comprehensive management strategies.